1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure. 
The treatment of the bleeding diathesis of renal failure remains unsatisfactory.  1-Deamino-8-D-arginine vasopressin (DDAVP) has recently been shown to shorten the prolonged bleeding time of renal failure and may as a result diminish the risk of clinical hemorrhage.  We describe 2 cases where DDAVP was used successfully in the management of hemorrhage in the setting of renal insufficiency.